期刊文献+

Exendin-4结构的稳定性及其微球制备 被引量:1

Stability of Exendin-4 Structure and Preparation of Exendin-4 Microspheres
原文传递
导出
摘要 目的分析影响Exendin-4二级结构稳定性的各种因素,并制备Exendin-4微球。方法利用远紫外圆二色光谱(Circular dichroism,CD)技术,分析pH值、温度、高速搅拌、油水界面对Exendin-4二级结构的影响及冰浴和蛋白质保护剂对其二级结构的保护作用。在此基础上,选用乳酸-羟基乙酸共聚物(PLGA)为成球材料,采用复乳法(W/O/W)制备Exendin-4微球,并对其理化性质进行评价。结果优化了实现Exendin-4二级结构稳定性的药剂学方法。制备的Exendin-4微球流动性良好,球形圆整,平均粒径为(25.3±3.2)μm,结构保持完好,微球的载药量约为1.0%,包封率为72.3%±2.4%,微球的释药曲线符合Higuchi释放模型,未发生明显的突释,具有良好的缓释效果。结论采取适当的药剂学方法,可以保证Exendin-4结构的稳定性并制备出理化性质合格的微球。 Objective To analyze various factors influencing the stability of secondary structure of Exendin-4 and prepare Exendin-4 microspheres.Methods The influence of pH value,temperature,high-speed homogenization and oil-water interface on the secondary structure of Exendin-4 as well as protective effect of ice bath and protein stabilizer on the structure were studied by far ultraviolet circular dichroism(CD)technique,based on which Exendin-4 microspheres were prepared with PLGA by W /O /W method and evaluated for physico-chemical property.Results The pharmaceutical method for stabilizing the secondary structure of Exendin-4 was optimized.The prepared Exendin-4 microspheres showed good fluidity,regular shape and intact structure,at a mean size of(25.3 ± 3.2)μm.The drug-loading and encapsulation efficiency of the microspheres were about 1.0% and 72.3% ± 2.4% re-spectively.The release curve of prepared microspheres was in a Higuchi mode,and no burst release was observed,indicating that the microspheres were controlled-released.Conclusion The stability of structure of Exendin-4 was kept by an appropriate pharmaceutical method,and Exendin-4 microspheres qualified in physico-chemical tests were prepared.
出处 《中国生物制品学杂志》 CAS CSCD 2009年第10期993-997,共5页 Chinese Journal of Biologicals
关键词 EXENDIN-4 二级结构 稳定性 圆二色光谱 乳酸-羟基乙酸共聚物 微球 Exendin-4 Secondary structure Stability Circular dichroism(CD) PLGA Microspheres
  • 相关文献

参考文献10

  • 1Arulmozhia DK,Portha B.GLP-1based therapy for type2diabetes[].European Journal of Pharmaceutical Sciences.2006
  • 2Lovshin JA,Drucker DJ.Incretin-based therapies for type2dia-betes mellitus[].Nat Rev Endocrinol.2009
  • 3Kendall DM,Cuddihy RM,Bergenstal RM.Clinical application of incretin-based therapy:therapeutic potential,patient selection and clinical use[].The American Journal of Medicine.2009
  • 4Nielsen LL,Young AA,Parkes DG.Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes[].Regulatory Peptides.2004
  • 5Iltz JL,Baker DE,Setter SM,et al.Exenatide:an incretin mimetic for thetreatment of type2diabetes mellitus[].Clinical Therapeutics.2006
  • 6Sinha V R,Trehan A.Biodegradable microspheres for protein delivery[].Journal of Controlled Release.2003
  • 7Freiberg S,Zhu XX.Polymer microspheres for controlled drug release[].International Journal of Pharmaceutics.2004
  • 8Sharon M. Kelly,Thomas J. Jess and Nicholas C. Price.How to study proteins by circular dichroism[].Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics.2005
  • 9Bierzynski A.Methods of peptide conformation studies[].Acta Biochimica Polonica.2001
  • 10Jorgensen L,Moeller E H,van de Weert M, et al.Preparing and evaluating delivery systems for proteins[].European Journal of Pharmaceutical Sciences.2006

同被引文献8

  • 1艾静,王宁,杜杰,杨梅,刘萍,杜智敏,杨宝峰.Wistar大鼠2型糖尿病动物模型的建立[J].中国药理学通报,2004,20(11):1309-1312. 被引量:33
  • 2徐风华,张强.蛋白质/多肽药物聚乳酸/乳酸-羟基乙酸共聚物微球研究进展(英文)[J].药学学报,2007,42(1):1-7. 被引量:5
  • 3SINHA V R, TREHAN A. Biodegradable microspheres for protein delivery [ J ]. J Controlled Release, 2003, 90 ( 3 ) :261-280.
  • 4JORGENSEN L, MOELLER E H, VAN DE WEERT M, et al. Preparing and evaluating delivery systems for proteins [ J]. Ear J Pharm Sci, 2006, 29(3-4) :174-182.
  • 5ARULMOZHIA D K, PORTHA B. GLP-I based therapy for type 2 diabetes [J]. Eur J Pharm Sci, 2006, 28(1-2) :96-108.
  • 6NIELSEN L L, YOUNG A A, PARKES D G. Pharmacology of ex- enatide (synthetic exendin-4): A potential therapeutic for im- proved glycemic control of type 2 diabetes [ J ]. Regul Pept, 2004, 117(2) :77-88.
  • 7WANG P, SUN W H. A new drug for type 2 diabetes: Exenatide [J].中国药学杂志,2007,42(8):637-638.
  • 8章成昌,陈建华.长效化Exendin-4的研究进展[J].现代生物医学进展,2013,13(2):371-374. 被引量:4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部